论文部分内容阅读
1994年7月在北京举行了链激酶溶栓治疗急性心肌梗塞的研讨会。来自北京、上海、天津、广东、辽宁、黑龙江、山东、河北等地的116名代表参加了研讨会。胡大一教授代表参加中国评价链激酶(streptase,BEHRING)在心肌梗塞后冠状动脉再灌注的大规模临床试验的48家医院公布了试验结果。加拿大 Hamilton总医院内科主任。McMaster 大学内科教授 Turpie 到会阼了关于急性心肌梗塞溶栓的进展。与会代表针对中
July 1994 held in Beijing streptokinase thrombolytic therapy of acute myocardial infarction seminar. 116 delegates from Beijing, Shanghai, Tianjin, Guangdong, Liaoning, Heilongjiang, Shandong and Hebei participated in the seminar. Professor Hu Dayi on behalf of China to participate in the evaluation of streptase (BEHRING) in myocardial infarction after coronary reperfusion large-scale clinical trial of 48 hospitals announced the results of the trial. Director General, Hamilton General Hospital, Canada. Turpie, a professor of internal medicine at McMaster University, will discuss the progress of thrombolysis in acute myocardial infarction. Delegates targeted at